NCT04930146

Brief Summary

Traumatic brain injury (Traumatic brain injury, TBI) can be derived from various forms of injury, including blunt trauma, penetrating or acceleration/deceleration force caused by head injury.There are some study data show that acupuncture treatment has a superficial effect on the prognosis of traumatic brain injury and can limit the progression of secondary brain injury, but the effect of early bloodletting at the Jing-points on TBI patients still unknown. In our study, the investigators have proposed a randomized, controlled study design and plan to evaluate the efficacy and safety of Jing-point puncture to improve consciousness and neurological function in patients with TBI. In addition, an objective meridian instrument analysis was added to analyze the energy distribution in the meridian of TBI patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 9, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 18, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2024

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

3 years

First QC Date

June 9, 2021

Last Update Submit

June 16, 2021

Conditions

Keywords

Traumatic brain injury, TBIBloodlettingacupuncture

Outcome Measures

Primary Outcomes (5)

  • GCS(Glasgow Coma Scale)

    To assess the recovery of consciousness. Lower GCS scores are correlated with higher risk of death.

    4 weeks

  • Barthel index

    To assess the activities of daily life.

    4 weeks

  • Muscle power

    To assess the recovery of muscle power.

    4 weeks

  • mGOS(Modified Glasgow Outcome Score)

    To assess the neurological outcomes, score 1 to 5. the higher the score, the better outcome.

    4 weeks

  • RTS (Revised Trauma Score)

    To assess the physiologic condition of patients. The Revised Trauma Score is made up of a three categories: Glasgow Coma Scale, systolic blood pressure, and respiratory rate. The score range is 0-12. A lower score indicates a higher severity of injury.

    4 weeks

Secondary Outcomes (1)

  • Meridian energy assessment

    4 weeks

Study Arms (4)

Intervention group (Severe)

EXPERIMENTAL

A patient's Glasgow Coma Score (GCS) between 5-8 1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments. 2. Evaluating the meridian energy by M.E.A.D

Other: acupuncture and bloodletting

Control group (Severe)

NO INTERVENTION

A patient's Glasgow Coma Score (GCS) between 5-8 1. Conventional treatment. 2. Evaluating the meridian energy by M.E.A.D

Intervention group (Moderate)

EXPERIMENTAL

A patient's Glasgow Coma Score (GCS) between 9-13 1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments. 2. Evaluating the meridian energy by M.E.A.D

Other: acupuncture and bloodletting

Control group (moderate)

NO INTERVENTION

A patient's Glasgow Coma Score (GCS) between 9-13 1. Conventional treatment. 2. Evaluating the meridian energy by M.E.A.D

Interventions

bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.

Intervention group (Moderate)Intervention group (Severe)

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with moderate to severe head injury are admitted to the ICU (Intensive Care Unit). patient with stable vital sign and the GCS (Glasgow coma volume) between 5-13 will be included.
  • Patient with normal consciousness and no cognitive or motor function disease before brain injury.
  • Patient aged between 20 to 80 years old and is willing to sign the consent (the agent can sign on behalf of patient).

You may not qualify if:

  • Patients who are vital sign unstable and with severe complication.
  • Patients combined with other terminal illness such as cancer in terminal stage, liver failure, end stage renal failure and so on.
  • Pregnant patients.
  • Any other conditions deemed unsuitable by the physician in charge.
  • Patients (agent of the patient) who did not sign the consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Brain Injuries, Traumatic

Interventions

Acupuncture TherapyBloodletting

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhlebotomyPunctures

Study Officials

  • wei Ling Chou

    Chang Gung Medical Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 18, 2021

Study Start

June 8, 2021

Primary Completion

June 7, 2024

Study Completion

June 7, 2024

Last Updated

June 21, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations